IACCINO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 1.895
AS - Asia 1.185
EU - Europa 768
SA - Sud America 171
AF - Africa 30
OC - Oceania 3
Totale 4.052
Nazione #
US - Stati Uniti d'America 1.816
SG - Singapore 628
IT - Italia 374
CN - Cina 257
BR - Brasile 133
DE - Germania 115
VN - Vietnam 109
IN - India 91
GB - Regno Unito 65
FI - Finlandia 53
SE - Svezia 49
CA - Canada 47
HK - Hong Kong 24
MX - Messico 21
FR - Francia 17
NL - Olanda 13
ZA - Sudafrica 13
CZ - Repubblica Ceca 12
ES - Italia 12
PL - Polonia 12
AR - Argentina 11
ID - Indonesia 10
KR - Corea 10
BD - Bangladesh 9
JP - Giappone 9
RU - Federazione Russa 9
UA - Ucraina 9
EC - Ecuador 6
IQ - Iraq 6
MA - Marocco 6
PK - Pakistan 6
AT - Austria 5
CL - Cile 5
CO - Colombia 5
LT - Lituania 5
PE - Perù 5
RO - Romania 5
NP - Nepal 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
DZ - Algeria 3
EE - Estonia 3
GR - Grecia 3
MY - Malesia 3
TR - Turchia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CR - Costa Rica 2
ET - Etiopia 2
KE - Kenya 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
AU - Australia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GD - Grenada 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.052
Città #
San Jose 322
Singapore 281
Dallas 277
Ashburn 211
Chandler 148
Munich 91
Santa Clara 80
Catanzaro 71
Hefei 68
Bengaluru 67
Milan 53
Beijing 45
Ho Chi Minh City 45
Lawrence 43
Princeton 43
London 41
Turku 41
Chicago 32
Ottawa 27
Los Angeles 24
Hong Kong 22
Wilmington 22
Boardman 21
São Paulo 21
Napoli 16
Hanoi 13
Naples 13
Helsinki 12
Olomouc 12
Seattle 12
New York 11
Brooklyn 10
Des Moines 10
Rome 10
Shanghai 10
Johannesburg 9
Mexico City 9
Montreal 9
Warsaw 9
Hanover 8
San Francisco 7
Atlanta 6
Augusta 6
Boston 6
Guangzhou 6
Haiphong 6
Padova 6
Seoul 6
Taranto 6
Biên Hòa 5
Denver 5
Orem 5
Palermo 5
Paris 5
Providence 5
Redmond 5
Stockholm 5
Amsterdam 4
Assago 4
Foggia 4
Huế 4
Latina 4
Luni 4
Madrid 4
Manchester 4
Mumbai 4
Norwalk 4
Rio de Janeiro 4
The Dalles 4
Buffalo 3
Campinas 3
Cape Town 3
Caserta 3
Chennai 3
Chieti 3
Cosenza 3
Curitiba 3
Da Nang 3
Derby 3
Ferrara 3
Frankfurt am Main 3
Heiwajima 3
Houston 3
Huddinge 3
Jiaxing 3
Lahore 3
Lamezia Terme 3
Las Vegas 3
Louisville 3
Novara 3
Pagani 3
Phoenix 3
Redondo Beach 3
Redwood City 3
Reggio Calabria 3
Riyadh 3
Salvador 3
Shenzhen 3
Tashkent 3
Tokyo 3
Totale 2.505
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 148
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 102
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 97
A novel phage display based platform for exosome diversity characterization 92
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 88
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 88
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 84
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 83
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtk-gamma 83
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 82
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 81
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 80
Kitcre knock-in mice fail to fate-map cardiac stem cells 80
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 77
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder 75
Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. 74
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 73
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 73
Cancer-associated CD43 glycoforms as target of immunotherapy 73
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 68
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
The aftermath of the Merck's HIV vaccine trial 67
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 67
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 67
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 67
Collagen type V polymorphism in spontaneous quadriceps tendon ruptures 66
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 64
Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy 63
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 61
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 60
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 59
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 59
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 58
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 58
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 58
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 56
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 55
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 54
Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting 54
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 54
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 54
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 54
Neuronally Derived Extracellular Vesicles’ Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson’s Disease from Essential Tremor 54
Phage Display: An Overview in Context to Drug Discovery 52
Belantamab mafodotin in multiple myeloma 51
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 51
Identification of differentially expressed microRNAs in the skin of experimentally sensitized naturally affected atopic beagles by next-generation sequencing 50
Insights into Thymus Development and Viral Thymic Infections 50
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 50
Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context 48
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 47
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 47
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 46
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 46
Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study 44
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 44
Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk 43
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease 43
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 42
Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease 42
Expression of Serum Exosomal miRNA 122 and Lipoprotein Levels in Dogs Naturally Infected by Leishmania infantum: A Preliminary Study 40
Elotuzumab in multiple myeloma 38
Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer's disease 37
Harnessing the potential of metalloproteinases in extracellular vesicles: a window of opportunity for aneurysm management 37
Editorial: New perspectives on osteoclasts in health and disease 36
Isatuximab in multiple myeloma 30
Peptide-guided targeting of GPR55 for anti-cancer therapy 25
Short-term therapeutic effectiveness of tezepelumab in patients with severe asthma: A real-world study 20
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 18
null 6
Totale 4.161
Categoria #
all - tutte 32.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 19 0 7
2021/2022205 6 0 4 41 11 8 13 49 16 36 17 4
2022/2023482 89 35 30 22 44 39 13 30 86 27 50 17
2023/2024345 74 46 32 28 21 69 1 7 9 4 24 30
2024/2025985 126 36 47 27 88 98 23 19 141 35 140 205
2025/20261.943 156 217 333 205 208 115 270 109 192 138 0 0
Totale 4.161